JohnHoseiYimMD

PubMed

• PD-L1-expressing tumor-associated macrophages are immunostimulatory and associate with good clinical outcome in human breast cancer.
  Wang, L., Guo, W., Guo, Z., Yu, J., Tan, J., Simons, D., Hu, K., Liu, X., Zhou, Q., Zheng, Y., Colt, E., Yim, J., Waisman, J., Lee, P.> ;Cell Reports. Medicine. 2024 Feb 20
• 1 citations
  Baicalein activates 5' adenosine monophosphate-activated protein kinase, inhibits the mammalian target of rapamycin, and exhibits antiproliferative effects in pancreat...
  Kristen E Limbach, Wei Wen, Quanhua Xing, Jin Yan, John H Yim> ;Surgery. 2023 Jan 1
• 22 citations
  Phase II Trial of Neoadjuvant Carboplatin and Nab-Paclitaxel in Patients with Triple-Negative Breast Cancer.
  Yuan Yuan, Jin Sun Lee, Susan E. Yost, Sierra Min Li, Paul Frankel, Christopher Ruel, Daniel Schmolze, Kim Robinson, Aileen Tang, Norma Martinez, Daphne Stewart, James...> ;The Oncologist. 2021 Mar 1
• 22 citations
  Inhibition of Autophagy Amplifies Baicalein-Induced Apoptosis in Human Colorectal Cancer.
  Thuy Phan, Vu H. Nguyen, Marcela A’lincourt Salazar, Paul Wong, Don J. Diamond, John H. Yim, Laleh G. Melstrom> ;Molecular Therapy Oncolytics. 2020 Dec 16
• 7 citations
  Synergistic Anti-Tumor Activity by Targeting Multiple Signaling Pathways in Ovarian Cancer.
  Wei Wen, Ernest S. Han, Thanh H. Dellinger, Leander X Lu, Jun Wu, Richard Jove, John H. Yim> ;Cancers. 2020 Sep 10
• 51 citations
  Breast cancer induces systemic immune changes on cytokine signaling in peripheral blood monocytes and lymphocytes
  Lei Wang, Diana L. Simons, Xuyang Lu, Travis Y. Tu, Christian Avalos, Andrew Y. Chang, Frederick M. Dirbas, John H. Yim, James Waisman, Peter P. Lee> ;Ebiomedicine. 2020 Feb 1
• 6 citations
  Insurance Status Predicts Survival in Women with Breast Cancer: Results of Breast and Cervical Cancer Treatment Program in California.
  Rebecca A. Nelson, Zeynep Bostanci, Veronica Jones, Joanne E. Mortimer, Amy C. Polverini, Lesley Taylor, Lisa D. Yee, John H. Yim, Laura Kruper> ;Annals of Surgical Oncology. 2020 Jan 21
• 27 citations
  Phase I clinical trial of the combination of eribulin and everolimus in patients with metastatic triple-negative breast cancer
  Jin Sun Lee, Susan E. Yost, Suzette Blanchard, Daniel Schmolze, Hongwei Holly Yin, Raju Pillai, Kim Robinson, Aileen Tang, Norma Martinez, Jana Portnow, Wei Wen, John ...> ;Breast Cancer Research. 2019 Nov 8
• 75 citations
  Resident memory CD8+ T cells within cancer islands mediate survival in breast cancer patients
  Colt Egelston, Christian Avalos, Travis Y. Tu, Anthony Rosario, Roger Wang, Shawn Solomon, Gayathri Srinivasan, Michael S. Nelson, Yinghui Huang, Min Hui Lim, Diana L....> ;JCI Insight. 2019 Oct 3
• 20 citations
  Eribulin Synergistically Increases Anti-Tumor Activity of an mTOR Inhibitor by Inhibiting pAKT/pS6K/pS6 in Triple Negative Breast Cancer.
  Wei Wen, Emily Marcinkowski, David Luyimbazi, Thehang Luu, Quanhua Xing, Jin Yan, Yujun Wang, Jun Wu, Yuming Guo, Dylan Tully, Ernest S. Han, Susan E. Yost, Yuan Yuan,...> ;Cells. 2019 Aug 30
• 7 citations
  Increasing Antitumor Activity of JAK Inhibitor by Simultaneous Blocking Multiple Survival Signaling Pathways in Human Ovarian Cancer.
  Wei Wen, Ernest S. Han, Thanh H. Dellinger, Jun Wu, Yuming Guo, Ralf Buettner, David Horne, Richard Jove, John H. Yim> ;Translational Oncology. 2019 May 26
• 97 citations
  Connecting blood and intratumoral T reg cell activity in predicting future relapse in breast cancer
  Lei Wang, Diana L. Simons, Xuyang Lu, Travis Y. Tu, Shawn Solomon, Roger Wang, Anthony Rosario, Christian Avalos, Daniel Schmolze, John H. Yim, James Waisman, Peter P....> ;Nature Immunology. 2019 Jul 8
• 11 citations
  Differential gene expression and AKT targeting in triple negative breast cancer
  Feng-Mao Lin, Susan E. Yost, Wei Wen, Paul Frankel, Daniel Schmolze, Peiguo Chu, Yate-Ching Yuan, Zheng Liu, John H. Yim, Zhen Chen, Yuan Yuan> ;Oncotarget. 2019 Jun 8
• 18 citations
  Combination therapy with BYL719 and LEE011 is synergistic and causes a greater suppression of p-S6 in triple negative breast cancer
  Yuan Yuan, Wei Wen, Susan E. Yost, Quanhua Xing, Jin Yan, Ernest S. Han, Joanne E. Mortimer, John H. Yim> ;Scientific Reports. 2019 May 17
• 22 citations
  Identification of Tissue-Specific DNA Methylation Signatures for Thyroid Nodule Diagnostics.
  John H. Yim, Audrey H. Choi, Arthur X. Li, Hanjun Qin, Sue Chang, Sun-Wing Tong, Peiguo Chu, Byung-Wook Kim, Daniel Schmolze, Ryan Lew, Yasmine Ibrahim, Valeriy Poroyk...> ;Clinical Cancer Research. 2019 Jan 15
• 84 citations
  Human breast tumor-infiltrating CD8+ T cells retain polyfunctionality despite PD-1 expression.
  Colt Egelston, Christian Avalos, Travis Y. Tu, Diana L. Simons, Grecia Jimenez, Jae Y. Jung, Laleh G. Melstrom, Kim Margolin, John H. Yim, Laura Kruper, Joanne E. Mort...> ;Nature Communications. 2018 Oct 16
• 29 citations
  Sentinel lymph node B cells can predict disease-free survival in breast cancer patients
  Kim Blenman, Ting-Fang He, Paul Frankel, Nora H. Ruel, Erich J. Schwartz, David N. Krag, Lee K. Tan, John H. Yim, Joanne E. Mortimer, Yuan Yuan, Peter P. Lee> ;NPJ Breast Cancer. 2018 Aug 23
• 20 citations
  Age greater than 60 years portends a worse prognosis in patients with papillary thyroid cancer: should there be three age categories for staging?
  Rondi M. Kauffmann, J. Blair Hamner, Philip H.G. Ituarte, John H. Yim> ;BMC Cancer. 2018 Mar 22
• 24 citations
  Ruxolitinib synergistically enhances the anti-tumor activity of paclitaxel in human ovarian cancer
  Ernest S. Han, Wei Wen, Thanh H. Dellinger, Jun Wu, Selena A Lu, Richard Jove, John H. Yim> ;Oncotarget. 2018 Jan 31
• Correction: Genomic mutation-driven metastatic breast cancer therapy: a single center experience.
  Yuan Yuan, Susan E. Yost, John H. Yim, Yate-Ching Yuan, Nicola M. Solomon, Isa Mambetsariev, Sumanta K. Pal, Paul Frankel, Ravi Salgia, Susan L. Neuhausen, Joanne E. M...> ;Oncotarget. 2017 Sep 22
• 20 citations
  Characterization of patient-derived tumor xenografts (PDXs) as models for estrogen receptor positive (ER+HER2- and ER+HER2+) breast cancers.
  Noriko Kanaya, George Somlo, Jun Wu, Paul Frankel, Masaya Kai, Xueli Liu, Shang Wu, Duc Nguyen, Nymph Chan, Meng Yin Hsieh, Michele Kirschenbaum, Laura Kruper, Courtne...> ;The Journal of Steroid Biochemistry and Molecular Biology. 2017 Jun 1
• 48 citations
  Human brain metastatic stroma attracts breast cancer cells via chemokines CXCL16 and CXCL12
  Brile Chung, Ali A. Esmaeili, Sailesh Gopalakrishna-Pillai, John P. Murad, Emily S. Andersen, Naveen Kumar Reddy, Gayathri Srinivasan, Brian Armstrong, Caleb Chu, Youn...> ;NPJ Breast Cancer. 2017 Mar 2
• 27 citations
  IL6 Signaling in Peripheral Blood T Cells Predicts Clinical Outcome in Breast Cancer
  Lei Wang, Andrea K. Miyahira, Diana L. Simons, Xuyang Lu, Andrew Y. Chang, Carrie Wang, Maria A. Suni, Vernon C. Maino, Frederick M. Dirbas, John H. Yim, James Waisman...> ;Cancer Research. 2017 Mar 1
• 26 citations
  Cinnamon extract reduces VEGF expression via suppressing HIF‐1α gene expression and inhibits tumor growth in mice
  Keqiang Zhang, Ernest S. Han, Thanh H. Dellinger, Jianming Lu, Sangkil Nam, Richard A. Anderson, John H. Yim, Wei Wen> ;Molecular Carcinogenesis. 2017 Feb 1
• 13 citations
  Genomic mutation-driven metastatic breast cancer therapy: a single center experience
  Yuan Yuan, Susan E. Yost, John H. Yim, Yate-Ching Yuan, Nicola M. Solomon, Isa Mambetsariev, Sumanta K. Pal, Paul Frankel, Ravi Salgia, Susan L. Neuhausen, Joanne E. M...> ;Oncotarget. 2017 Jan 3
• Join now to see all